Agilent Technologies EV 2011-2026 | A

EV Jährlich Agilent Technologies

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
45.8 B	39.3 B	28.7 B	24.9 B	23.2 B	15.6 B	15.2 B	16.7 B	15.8 B	12.5 B	10.5 B

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
45.8 B	10.5 B	22.6 B

EV anderer Aktien in der Diagnostik & Forschung

Name	EV	Preis	% 24h	Marktkapitalisierung	Land
Centogene N.V. CNTG	-19.1 M	-	-6.23 %	$ 30.6 M	Germany
Aspira Women's Health AWH	10.6 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	15 M	-	-13.05 %	$ 7.29 M	USA
Castle Biosciences CSTL	665 M	$ 25.76	3.75 %	$ 716 M	USA
DermTech DMTK	70.4 M	-	-11.32 %	$ 2.94 M	USA
Danaher Corporation DHR	145 B	$ 197.13	3.2 %	$ 140 B	USA
Enzo Biochem ENZ	-22.7 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	22 B	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	502 M	$ 16.46	3.46 %	$ 498 M	USA
CareDx, Inc CDNA	1.04 B	$ 18.77	6.23 %	$ 1 B	USA
Oxford Immunotec Global PLC OXFD	26.2 M	-	-	$ 562 M	Britain
Guardant Health GH	15.2 B	$ 98.12	5.17 %	$ 12.3 B	USA
DexCom DXCM	28.2 B	$ 65.04	3.05 %	$ 25.4 B	USA
Akumin AKU	1.64 B	-	-17.87 %	$ 25.9 M	Canada
Heska Corporation HSKA	851 M	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	3.16 M	-	-20.0 %	$ 1.06 M	USA
Burning Rock Biotech Limited BNR	433 M	$ 16.49	2.49 %	$ 177 M	China
Co-Diagnostics CODX	-1.92 M	$ 4.4	101.83 %	$ 5.85 M	USA
ICON Public Limited Company ICLR	26.4 B	$ 111.47	4.02 %	$ 9.19 B	Irlanda
Illumina ILMN	15.3 B	$ 131.01	3.61 %	$ 20.8 B	USA
Accelerate Diagnostics AXDX	92.6 M	-	-61.36 %	$ 2.46 M	USA
IQVIA Holdings IQV	49.6 B	$ 175.27	2.78 %	$ 30.1 B	USA
Global Cord Blood Corporation CO	-2.77 B	-	-	$ 399 M	China
Fluidigm Corporation FLDM	6.64 M	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	9.21 B	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	251 M	-	0.12 %	$ 80.1 M	China
Laboratory Corporation of America Holdings LH	33.1 B	$ 272.99	1.42 %	$ 22.7 B	USA
Lantheus Holdings LNTH	5.9 B	$ 79.33	1.6 %	$ 5.35 B	USA
Charles River Laboratories International CRL	11.4 B	$ 178.81	5.42 %	$ 8.86 B	USA
PRA Health Sciences, Inc. PRAH	5.02 B	-	-	$ 10.7 B	USA
Medpace Holdings MEDP	14 B	$ 522.44	2.74 %	$ 15.1 B	USA
Motus GI Holdings MOTS	568 K	-	-34.28 %	$ 263 K	Israel
Mettler-Toledo International MTD	32.1 B	$ 1 314.35	3.49 %	$ 27.1 B	Schweiz
Myriad Genetics MYGN	598 M	$ 4.91	3.61 %	$ 455 M	USA
NeoGenomics NEO	1.85 B	$ 8.46	4.96 %	$ 1.08 B	USA
Biodesix BDSX	142 M	$ 14.78	1.69 %	$ 1.92 B	USA
Neogen Corporation NEOG	2.26 B	$ 10.59	6.06 %	$ 2.3 B	USA
OpGen OPGN	10.3 M	-	-16.95 %	$ 1.54 M	USA
Natera NTRA	5.53 B	$ 217.44	3.9 %	$ 21.4 B	USA
Pacific Biosciences of California PACB	1.21 B	$ 1.53	6.25 %	$ 459 M	USA
PerkinElmer PKI	4 B	-	-0.91 %	$ 14.7 B	USA
Quotient Limited QTNT	393 M	-	-11.32 %	$ 1.1 M	Schweiz
Precipio PRPO	42.5 M	$ 28.84	1.19 %	$ 46.3 M	USA
Personalis PSNL	229 M	$ 6.72	8.91 %	$ 398 M	USA
QIAGEN N.V. QGEN	11.3 B	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	990 K	$ 2.72	1.12 %	$ 88.3 K	USA
Biomerica BMRA	6.63 M	$ 2.18	0.93 %	$ 5.01 M	USA
BioNano Genomics BNGO	34.1 M	$ 1.16	-0.85 %	$ 6.32 M	USA
Interpace Biosciences IDXG	16.3 M	$ 2.0	1.27 %	$ 8.85 M	USA